EXACERBATIONS OF THE USE OF SELENIUM-CONTAINING DRUGS IN PREGNANT WOMEN IN THE PREVENTION OF FETOPLACENTAR DEFICIENCY. Web med. [Internet]. 2025 Feb. 14 [cited 2025 Oct. 3];3(2):261-4. Available from: https://webofjournals.com/index.php/5/article/view/3279